Aurobindo Pharma shares gained 2% on Monday morning after a US-based unit, Aurolife Pharma, cleared an FDA plant inspection with VAI status. The gain follows...
Shares of Aurobindo Pharma soared nearly 6% in the afternoon session on February 8 after the drugmaker said its downline subsidiary Aurolife Pharma had been...